Clinical Trial

False Lumen Treatment for Prevention of Aortic Growth Using Shape Memory Polymer - First-in-Human Study (FLAGSHIP_FRA)

Name: False Lumen Treatment for Prevention of Aortic Growth Using Shape Memory Polymer - First-in-Human Study (FLAGSHIP_FRA) — clinical trial record (NCT06740721)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: FLAGSHIP_FRA

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

To determine the safety and feasibility of investigational product to reduce aortic dissection false lumen perfusion.

Protocol Amendment History 3 amendments

This ClinicalTrials.gov record has been amended 3 times since 2024-12-13; most recent amendment 2026-01-27.

Trial Details

NCT Number	NCT06740721
Lead Sponsor	Shape Memory Medical, Inc.
Conditions	Aortic Dissection
Enrollment	15 participants
Start Date	2026-10-01
Primary Completion	2027-01-04 (estimated)
Study Completion	2029-01-03 (estimated)
Updated on ClinicalTrials.gov	2026-01-29